SNMMI 2016: PET offers insight into triggers of autoimmune inflammation in MS

Huge Two-Day Clean Sweep Auction July 24-25th. Click Here to Bid!

Current Location:
> This Story

Log in or Register to rate this News Story
Forward Printable StoryPrint Comment




Alzheimers/Neurology Homepage

Startup raises over $6 million for early Alzheimer's detection AI With digital biomarkers, Altoida detects risk long before symptoms appear

Study shows 30 percent drop in unnecessary head CTs with BrainScope One May help ensure appropriate use of imaging

Mild combat-related brain trauma can be detected with magnetoencephalography (MEG) Superior to conventional neuroimaging techniques like MR, CT

AI tool matches radiologist in amyloid detection for Alzheimer's Processes entire whole-brain slice with 98.7 percent accuracy

New study shows value of 7T MR for evaluating MS progression Can detect cortical lesions better than conventional scanners

PET uncovers abnormal tau deposits associated with CTE in live subjects May enable diagnosis of CTE in living people one day

Amyloid PET scans help with Alzheimer's clinical management New insights from the 11,000 patient IDEAS study

Women's brains appear three years younger than men's at the same age: PET study A machine-learning algorithm assisted with the analysis

APRINOIA and Celgene partner on promising PET tracer APN-1607 holds potential for visualizing tau pathology in diverse tauopathies

Opening blood brain barrier, focused ultrasound is closing therapy gap Insights from the 6th International Symposium on Focused Ultrasound

SNMMI 2016: PET offers insight into triggers of autoimmune inflammation in MS

by John W. Mitchell , Senior Correspondent
PET imaging is helping scientists better understand the triggers of autoimmune inflammation in multiple sclerosis (MS), according to a study presented yesterday at the 2016 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI). It's a disease that has eluded scientists for many years, but they are now getting closer to finding better management therapies.

“There has never been a cure,” Adam Rosenberg, the study's first author, told HCB News at the conference. “The strategy has been to help increase the length of the inactive phases of MS when a patient is not feeling its effects as acutely.”

Story Continues Below Advertisement

Servicing GE Nuclear Medicine equipment with OEM trained engineers

We offer full service contracts, PM contracts, rapid response, time and material,camera relocation. Nuclear medicine equipment service provider since 1975. Click or call now for more information 800 96 NUMED

Rosenberg added that MS tends to strike young people with a three to one ratio of females to males. According to the Multiple Sclerosis Foundation, it's the largest disabling neurological condition among young people, globally.

The research focused on using radiotracers to light up S1P1 receptors in MS lesions on the fatty tissue of nerves, called myelin. Myelin protects cells and enables cell signaling. But in people with MS, the myelin becomes inflamed and is gradually destroyed.

Rosenberg and his colleagues at the Washington School of Medicine generated a library of specially designed small molecules radiolabeled with fluorine-18 to attach to the S1P1 receptors. In rodents, these radiotracers bind with similar receptors, which can be viewed with a PET scan.

The research found that they could see an association between changes in the nerve cells and the radiotracer. Another important factor is that the tracer crossed the blood brain barrier, which has been a challenge in other MS research.

“Inflammation is the body’s physiological defense to harmful stimuli and it plays a critical role in the immune response to injury and infection,” said Zhude Tu, the study senior investigator and professor of PET at the university. “However, these same processes are associated with numerous pathological conditions when chronic inflammation is left unchecked.”

Alzheimers/Neurology Homepage

You Must Be Logged In To Post A Comment